US Retina LLC
$50.8M 8 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Lilly USA, LLC
Lilly USA, LLC reported $54,305,373.05 across General Payments, Research, and Ownership to 544,473 physicians and teaching hospitals across 544,519 transactions.
- $54.3M Top 10% payer
- All-tracks total
- 544,519 Top 1% volume
- Transactions
- 544,473 Top 1% reach
- Recipients
- +$7.8M
- General Payments vs PY2023
Lilly USA, LLC reported $54,305,373.05 across all CMS Open Payments tracks (General + Research + Ownership) to 544,473 physicians and teaching hospitals in Program Year 2024 - ranking #44 of 1,925 reporting manufacturers (0.4% of the all-tracks industry total); General Payments alone were $46,625,044.10, averaging $99.74 per recipient.
How Lilly USA, LLC's $54.3M all-tracks total breaks down
Lilly USA, LLC's payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
A
98/100
Total payments
A
100/100
Transaction volume
A
100/100
Physician reach
A
100/100
Payment type diversity
A
90/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer lilly-usa-llc Lilly USA, LLC
$54.3M · #44/1,925 · 0.4% industry · PY2024
- TOT $54.3M
- RANK #44
- SHARE 0.4%
- TXN 544,519
- RCP 544,473
- CAT 7
- GEN $46.6M
- ΔGEN +$7.8M
- TOP1 2.4%
- PY 2024
Volume peers
Nearest volume peer: US Retina LLC ($50.8M)
Lilly USA, LLC sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Lilly USA, LLC's CMS-reported General Payments increased by $7.8M (+20.1%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: LILLY USA, LLCPY2023: LILLY USA, LLCPY2024: Lilly USA, LLC. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $38,832,603.80
- PY2024
- $46,625,044.10
What the Data Shows for Lilly USA, LLC
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Lilly USA, LLC, that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 7 general-payment categories charted below, "Compensation for Services Other Than Consulting" is the largest at $28.1M across 21,467 transactions, 60.3% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Compensation for Services Other Than Consulting" leads Lilly USA, LLC's 7-category general-payment breakdown at $28.1M, 60.3% of the reported total.
Lilly USA, LLC reports 7 general-payment categories - the top three are Compensation for Services Other Than Consulting (60.3%), Food and Beverage (22.9%), and Travel and Lodging (7.3%). The remaining 4 categories make up 9.5% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Lilly USA, LLC divides its payments
Top payment categories by total reported dollar volume
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Compensation for Services Other Than Consulting | $28.1M | 21,467 | 60.3% |
| Food and Beverage | $10.7M | 508,263 | 22.9% |
| Travel and Lodging | $3.4M | 12,658 | 7.3% |
| Grant | $2.3M | 12 | 5.0% |
| Consulting Fee | $1.8M | 600 | 3.8% |
| Space Rental or Facility Fees | $255.2K | 106 | 0.5% |
| Education | $102.9K | 1,367 | 0.2% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $2,365,382.86 (5.1%) of $46,625,044.10 in this company's General Payments records across 121,822 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Lilly USA, LLC
The five named recipients with the highest reported General Payments from this company
- 1
Cpmc-R.k. Davies Medical Center
$1,115,920.00 across 3 reported transactions
- 2
Henry Ford Hospital
$635,253.00 across 8 reported transactions
- 3
Reading Hospital and Medical Center
$367,000.00 across 1 reported transactions
- 4
Stacy B Brown
$133,565.84 across 261 reported transactions
- 5
Chesahna Kindred Weaver
$113,644.02 across 108 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Lilly USA, LLC ranks #44 of 1,925 by total payments (top 2% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #1,823 of 1,838 by HHI (bottom 1% least concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Regeneron Healthcare Solutions, Inc. : $24.7M total payments, HHI 19
- GlaxoSmithKline, LLC. : $26.4M total payments, HHI 18
- Intuitive Surgical, Inc. : $74.2M total payments, HHI 18
- RedHill Biopharma Inc. : $37.3K total payments, HHI 18
- Kestra Medical Technology Services, Inc. : $515.4K total payments, HHI 17
- Aytu BioPharma, Inc. : $14.7K total payments, HHI 17
- Lilly USA, LLC (this company) : $46.6M total payments, HHI 16
- 180 Medical, Inc. : $86.9K total payments, HHI 13
- Janssen Biotech, Inc. : $30.9M total payments, HHI 13
- Amphastar Pharmaceuticals, Inc. : $41.3K total payments, HHI 13
- E.R. Squibb & Sons, L.L.C. : $31.0M total payments, HHI 12
- Aspira Women's Health Inc : $74.7K total payments, HHI 12
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Lilly USA, LLC's, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Lilly USA, LLC.
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Lilly USA, LLC.
Showing 6 of 1,924 companies with CMS-reported payment data.
Bayer Healthcare Pharmaceuticals Inc.
$58.0M 146,928 recipients
Compare payment profiles
Smith+Nephew, Inc.
$50.5M 71,450 recipients
Compare payment profiles
Vektor Medical Inc.
$49.6M 56 recipients
Compare payment profiles
Novo Nordisk AS
$49.2M 804 recipients
Compare payment profiles
Biogen, Inc.
$59.9M 36,001 recipients
Compare payment profiles
Put this to use
Lilly USA, LLC ranks #44 of 1,925 by all-tracks total payments, led by "Compensation for Services Other Than Consulting".
- See where Lilly USA, LLC sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Compensation for Services Other Than Consulting" spend across every manufacturer, not just Lilly USA, LLC. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.